These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1104216)

  • 1. Metabolic responses to monocomponent human insulin infusions in normal subjects and patients with liver and endocrine disease.
    West TE; Owens D; Sönksen PH; Srivastava MC; Tompkins CV; Nabarro JD
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):573-84. PubMed ID: 1104216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids.
    Srivastava MC; Oakley NW; Tompkins CV; Sönksen PH; Wynn V
    Eur J Clin Invest; 1975 Sep; 5(5):425-33. PubMed ID: 1102319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolic clearance rate, apparent distribution space and plasma half-disappearance time of unlabelled human growth hormone in normal subjects and in patients with liver disease, renal disease, thyroid disease and diabetes mellitus.
    Owens D; Srivastava MC; Tompkins CV; Nabarro JD; Sönksen PH
    Eur J Clin Invest; 1973 Jul; 3(4):284-94. PubMed ID: 4760050
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of insulin secretion during fasting hyperglycemia in adult diabetics and in nondiabetic subjects during infusion of glucose.
    Goodner CJ; Conway MJ; Werbach JH
    J Clin Invest; 1969 Oct; 48(10):1878-87. PubMed ID: 5822593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
    Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
    Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of small but sustained elevations in circulating growth hormone on fuel metabolism in growth hormone deficiency.
    Tamborlane WV; Genel M; Gianfredi S; Gertner JM
    Pediatr Res; 1984 Feb; 18(2):212-5. PubMed ID: 6366723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.
    Lerner RL; Porte D
    J Clin Invest; 1972 Jul; 51(7):1624-31. PubMed ID: 4555783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes.
    DeFronzo R; Deibert D; Hendler R; Felig P; Soman V
    J Clin Invest; 1979 May; 63(5):939-46. PubMed ID: 376552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus.
    Kimmerling G; Javorski C; Olefsky JM; Reaven GM
    Diabetes; 1976 Aug; 25(8):673-8. PubMed ID: 955298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of hormonal and metabolic effects of salbutamol infusion in normal subjects and insulin-requiring diabetics.
    Gündogdu AS; Brown PM; Juul S; Sachs L; Sönksen PH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1317-21. PubMed ID: 92670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hyperthyroidism on growth hormone secretion.
    Valcavi R; Dieguez C; Zini M; Muruais C; Casanueva F; Portioli I
    Clin Endocrinol (Oxf); 1993 May; 38(5):515-22. PubMed ID: 8330446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the growth-hormone response to insulin due to hypoglycaemia, hyperinsulinaemia or a fall in plasma free fatty acids?
    West TE; Sönksen PH
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):283-8. PubMed ID: 923107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes.
    Skouby SO; Andersen O; Kühl C
    Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion and insulin-like growth factor-I levels in active and controlled acromegaly.
    Hopkins KD; Holdaway IM
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):53-7. PubMed ID: 1559300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma insulin response to glucose infusion in obese non-diabetic and diabetic subjects.
    Velemínský J
    Horm Metab Res; 1980 Dec; 12(12):651-5. PubMed ID: 7009366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.